Anuja Mathew PHD
Title Assistant Professor
Institution University of Massachusetts Medical School
Department Medicine
Division Infectious Diseases And Immunology
Address University of Massachusetts Medical School
55 Lake Avenue North
Worcester MA 01655
Telephone 508-856-8414
Email
Other Positions
Institution UMMS - Graduate School of Biomedical Sciences
Department Immunology & Virology

Institution UMMS - Graduate School of Biomedical Sciences
Department Interdisciplinary Graduate Program

Institution UMMS - Graduate School of Biomedical Sciences
Department MD/PhD Program

Institution UMMS - Programs, Centers and Institutes
Department Center for Infectious Disease and Vaccine Research
Narrative

Academic Background

Education:

  • B.Sc. Women’s Christian College, Madras, India. 1989
  • M.Sc. Christian Medical College, Vellore, India. 1992
  • Ph.D. University of Massachusetts Medical School, Worcester, MA. 1999

Post-Doctoral Training:

  • Massachusetts General Hospital, 1999-2002

Research Interests

  • Human immune responses to dengue virus infections
  • Adaptive immune responses to dengue virus infections in humanized mice
  • Human and Murine immune responses to influenza infections
  • Dengue viruses

    Dengue viruses are mosquito-borne viruses that infect individuals in tropical and subtropical countries. They comprise four closely related but distinct viruses termed serotypes 1 through 4. Studies on humans infected with dengue provide strong evidence for an immunologic basis for the pathogenesis of severe disease DHF. We are involved with understanding T cell responses during acute dengue infection and in convalescence. We use samples obtained during the acute phase of dengue illness and up to 3 years post infection in a clinical cohort in Bangkok, Thailand to assess CD8 T cell responses to dengue. Using tetramers to epitope variants we assess serotype specificity and cross-reactivity of human T cells.

    Experimental manipulation of in vivo immune responses to dengue would be a desirable approach to explore models of DHF pathogenesis and to test the potential for candidate vaccines to prevent disease. Unfortunately there are no currently acceptable animal models to study dengue pathogenesis. We are evaluating “humanized” mice as a small animal model for the study of dengue virus infection, immunity, and disease.

    Influenza virus

    Despite significant advances, it is unclear how age-related changes in one or both compartments of the immune system contribute to the increased susceptibility of older individuals to infectious diseases such as influenza viral infections. We are interested in delineating the underlying mechanisms that affect the size and quality of immune responses to influenza. We would like to understand how aging impacts innate and adaptive immunity using murine models. Furthermore we would like to examine if innate immune responses are impaired in humans.

    Publications
    1. Jaiswal S, Pazoles P, Woda M, Shultz LD, Greiner DL, Brehm MA, Mathew A. Enhanced humoral and hla-a2-restricted dengue virus-specific t cell responses in humanized blt nsg mice. Immunology. 2012 Mar 2.
      View in: PubMed
     
    2. Mathew A, West K, Kalayanarooj S, Gibbons RV, Srikiatkhachorn A, Green S, Libraty D, Jaiswal S, Rothman AL. B-cell responses during primary and secondary dengue virus infections in humans. J Infect Dis. 2011 Nov; 204(10):1514-22.
      View in: PubMed
     
    3. Friberg H, Bashyam H, Toyosaki-Maeda T, Potts James A., Greenough T, Kalayanarooj S, Gibbons Robert V, Nisalak A, Srikiatkhachorn A, Green S, Stephens H.A.F., Rothman A. L., Mathew A. Nature: Sci Rep DOI:10.1038/srep00051. Cross-Reactivity and Expansion of Dengue-Specific T cells During Acute Primary and Secondary Infections in Humans. 2011; (1):51.
      View in: External Web Site
     
    4. O'Bryan JM, Potts JA, Bonkovsky HL, Mathew A, Rothman AL. Extended interferon-alpha therapy accelerates telomere length loss in human peripheral blood T lymphocytes. PLoS One. 2011; 6(8):e20922.
      View in: PubMed
     
    5. Hatch S, Endy TP, Thomas S, Mathew A, Potts J, Pazoles P, Libraty DH, Gibbons R, Rothman AL. Intracellular Cytokine Production by Dengue Virus-specific T cells Correlates with Subclinical Secondary Infection. J Infect Dis. 2011 May; 203(9):1282-91.
      View in: PubMed
     
    6. Green S, Ennis FA, Mathew A. Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines. Vaccine. 2011 Feb 11; 29(8):1666-76.
      View in: PubMed
     
    7. Beaumier CM, Jaiswal S, West KY, Friberg H, Mathew A, Rothman AL. Differential in vivo clearance and response to secondary heterologous infections by H2(b)-restricted dengue virus-specific CD8+ T cells. Viral Immunol. 2010 Oct; 23(5):477-85.
      View in: PubMed
     
    8. Friberg H, Burns L, Woda M, Kalayanarooj S, Endy TP, Stephens HA, Green S, Rothman AL, Mathew A. Memory CD8(+) T cells from naturally acquired primary dengue virus infection are highly cross-reactive. Immunol Cell Biol. 2011 Jan; 89(1):122-9.
      View in: PubMed
     
    9. Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, Rothman AL, Mathew A. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS One. 2009; 4(10):e7251.
      View in: PubMed
     
    10. Mathew A, O'Bryan J, Marshall W, Kotwal GJ, Terajima M, Green S, Rothman AL, Ennis FA. Robust intrapulmonary CD8 T cell responses and protection with an attenuated N1L deleted vaccinia virus. PLoS One. 2008; 3(10):e3323.
      View in: PubMed
     
    11. Mathew A, Rothman AL. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev. 2008 Oct; 225:300-13.
      View in: PubMed
     
    12. Beaumier CM, Mathew A, Bashyam HS, Rothman AL. Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. J Infect Dis. 2008 Feb 15; 197(4):608-17.
      View in: PubMed
     
    13. Hatch S, Mathew A, Rothman A. Dengue vaccine: opportunities and challenges. IDrugs. 2008 Jan; 11(1):42-5.
      View in: PubMed
     
    14. Yuan Q, Campanella GS, Colvin RA, Hamilos DL, Jones KJ, Mathew A, Means TK, Luster AD. Membrane-bound eotaxin-3 mediates eosinophil transepithelial migration in IL-4-stimulated epithelial cells. Eur J Immunol. 2006 Oct; 36(10):2700-14.
      View in: PubMed
     
    15. Mathew A, Terajima M, West K, Green S, Rothman AL, Ennis FA, Kennedy JS. Identification of murine poxvirus-specific CD8+ CTL epitopes with distinct functional profiles. J Immunol. 2005 Feb 15; 174(4):2212-9.
      View in: PubMed
     
    16. Mathew A, Medoff BD, Carafone AD, Luster AD. Cutting edge: Th2 cell trafficking into the allergic lung is dependent on chemoattractant receptor signaling. J Immunol. 2002 Jul 15; 169(2):651-5.
      View in: PubMed
     
    17. Medoff BD, Sauty A, Tager AM, Maclean JA, Smith RN, Mathew A, Dufour JH, Luster AD. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol. 2002 May 15; 168(10):5278-86.
      View in: PubMed
     
    18. Mathew A, MacLean JA, DeHaan E, Tager AM, Green FH, Luster AD. Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med. 2001 May 7; 193(9):1087-96.
      View in: PubMed
     
    19. Mathew A, Ennis FA, Rothman AL. Transient decreases in human T cell proliferative responses following vaccinia immunization. Clin Immunol. 2000 Aug; 96(2):100-7.
      View in: PubMed
     
    20. Mathew A, Kurane I, Green S, Vaughn DW, Kalayanarooj S, Suntayakorn S, Ennis FA, Rothman AL. Impaired T cell proliferation in acute dengue infection. J Immunol. 1999 May 1; 162(9):5609-15.
      View in: PubMed
     
    21. Mathew A, Kurane I, Green S, Stephens HA, Vaughn DW, Kalayanarooj S, Suntayakorn S, Chandanayingyong D, Ennis FA, Rothman AL. Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. J Virol. 1998 May; 72(5):3999-4004.
      View in: PubMed
     
    22. Mathew A, Kurane I, Rothman AL, Zeng LL, Brinton MA, Ennis FA. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest. 1996 Oct 1; 98(7):1684-91.
      View in: PubMed
     
    For assistance with using Profiles, please refer to the online tutorials at http://inside.umassmed.edu/is/profiles.aspx or contact the UMMS Help Desk at UMWHelpDesk@umassmed.edu or 508-856-8643.
     
    Keyword
    Last Name
    Institution
        
     
     
     
    Keywords   
    Dengue Virus
    Vaccinia virus
    CD8-Positive T-Lymphocytes
    T-Lymphocytes, Cytotoxic
    Dengue
    See all (136) keywords
    Co-Authors  
    Ennis, Francis
    Green, Sharone
    Hatch, Steven
    Libraty, Daniel
    Terajima, Masanori
    See all (11) people
    Physical Neighbors  
    de Almeida e Silva, Alexandre
    Ennis, Francis
    Co, Marydawn
    Blacklow, Neil
    Cheeseman, Sarah

    UMMS Home

    Intranet

    This is an official Page/Publication of the University of Massachusetts Worcester Campus
    Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
    Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572